Trials / Completed
CompletedNCT01776658
Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Sylentis, S.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this pilot study is to compare the analgesic effect of SYL1001 versus placebo in patients with ocular pain associated with Dry Eye Syndrome. General and local tolerability are also evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SYL1001 | Ocular topical administration of SYL1001 for 10 consecutive days |
| DRUG | Placebo | Ocular topical administration of placebo for 10 consecutive days |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-04-01
- First posted
- 2013-01-28
- Last updated
- 2015-05-25
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01776658. Inclusion in this directory is not an endorsement.